🇺🇸 FDA
Patent

US 10017762

Compositions and methods for treating or preventing lupus

granted A61KA61K2039/505A61K31/519

Quick answer

US patent 10017762 (Compositions and methods for treating or preventing lupus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K31/519, A61K31/5377, A61K31/5383